Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...

Some immunizations may be quietly protecting us from cognitive decline. How the medicine might do that is a mystery scientists are desperate to solve. A new study on two vaccines for older adults ...

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...

A recent study suggests that certain immunizations may unexpectedly protect against cognitive decline, potentially reducing ...

London: GSK plc has received approval from the US Food and Drug Administration (FDA) for a prefilled syringe presentation of ...

Shingrix is also better than Zostavax in preventing nerve pain that continues after a shingles rash has cleared -- about 90 percent effective versus 65 percent effective, the briefing stated.

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...